Search Results - "Pireddu, Annagrazia"

New therapeutic targets in pancreatic cancer by Lai, Eleonora, Puzzoni, Marco, Ziranu, Pina, Pretta, Andrea, Impera, Valentino, Mariani, Stefano, Liscia, Nicole, Soro, Paolo, Musio, Francesca, Persano, Mara, Donisi, Clelia, Tolu, Simona, Balconi, Francesca, Pireddu, Annagrazia, Demurtas, Laura, Pusceddu, Valeria, Camera, Silvia, Sclafani, Francesco, Scartozzi, Mario

“…•Pancreatic cancer has disappointing response to cytotoxic drugs and poor prognosis.•To date, no targetable driver genes have been recognized for pancreatic…”
Get full text

Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study by Cortellini, Alessio, Buti, Sebastiano, Bersanelli, Melissa, Giusti, Raffaele, Perrone, Fabiana, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Grassadonia, Antonino, Cannita, Katia, Tessitore, Alessandra, Zoratto, Federica, Veltri, Enzo, Malorgio, Francesco, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Cappellini, Gian Carlo Antonini, De Galitiis, Federica, Vitale, Maria Giuseppa, Rastelli, Francesca, Pergolesi, Federica, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Iacono, Daniela, Migliorino, Maria Rita, Gelibter, Alain, Occhipinti, Mario Alberto, Martella, Francesco, Inno, Alessandro, Gori, Stefania, Bracarda, Sergio, Zannori, Cristina, Mosillo, Claudia, Parisi, Alessandro, Porzio, Giampiero, Mallardo, Domenico, Fargnoli, Maria Concetta, Tiseo, Marcello, Santini, Daniele, Ascierto, Paolo A, Ficorella, Corrado

“…Background: We investigate the role of family history of cancer (FHC) and diagnosis of metachronous and/or synchronous multiple neoplasms (MN), during…”
Get full text

Clinical Outcomes of Patients with Advanced Cancer and Pre‐Existing Autoimmune Diseases Treated with Anti‐Programmed Death‐1 Immunotherapy: A Real‐World Transverse Study by Cortellini, Alessio, Buti, Sebastiano, Santini, Daniele, Perrone, Fabiana, Giusti, Raffaele, Tiseo, Marcello, Bersanelli, Melissa, Michiara, Maria, Grassadonia, Antonino, Brocco, Davide, Tinari, Nicola, De Tursi, Michele, Zoratto, Federica, Veltri, Enzo, Marconcini, Riccardo, Malorgio, Francesco, Garufi, Carlo, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Vitale, Maria Giuseppa, Sabbatini, Roberto, Bracarda, Sergio, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Chiari, Rita, Ricciuti, Biagio, Iacono, Daniela, Migliorino, Maria Rita, Rossi, Antonio, Porzio, Giampiero, Cannita, Katia, Ciciarelli, Valeria, Fargnoli, Maria Concetta, Ascierto, Paolo Antonio, Ficorella, Corrado

“…Background Patients with a history of autoimmune diseases (AIDs) have not usually been included in clinical trials with immune checkpoint inhibitors. Materials…”
Get full text

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable by Cortellini, Alessio, Bersanelli, Melissa, Buti, Sebastiano, Cannita, Katia, Santini, Daniele, Perrone, Fabiana, Giusti, Raffaele, Tiseo, Marcello, Michiara, Maria, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Zoratto, Federica, Veltri, Enzo, Marconcini, Riccardo, Malorgio, Francesco, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Vitale, Maria Giuseppa, Rastelli, Francesca, Pergolesi, Federica, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Chiari, Rita, Ricciuti, Biagio, De Giglio, Andrea, Iacono, Daniela, Gelibter, Alain, Occhipinti, Mario Alberto, Parisi, Alessandro, Porzio, Giampiero, Fargnoli, Maria Concetta, Ascierto, Paolo Antonio, Ficorella, Corrado, Natoli, Clara

“…Recent evidence suggested a potential correlation between overweight and the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients. We conducted a…”
Get full text

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients by Cortellini, Alessio, Chiari, Rita, Ricciuti, Biagio, Metro, Giulio, Perrone, Fabiana, Tiseo, Marcello, Bersanelli, Melissa, Bordi, Paola, Santini, Daniele, Giusti, Raffaele, Grassadonia, Antonino, Di Marino, Pietro, Tinari, Nicola, De Tursi, Michele, Zoratto, Federica, Veltri, Enzo, Malorgio, Francesco, Garufi, Carlo, Russano, Marco, Anesi, Cecilia, Zeppola, Tea, Filetti, Marco, Marchetti, Paolo, Berardi, Rossana, Rinaldi, Silvia, Tudini, Marianna, Silva, Rosa Rita, Pireddu, Annagrazia, Atzori, Francesco, Iacono, Daniela, Migliorino, Maria Rita, Porzio, Giampiero, Cannita, Katia, Ficorella, Corrado, Buti, Sebastiano

“…Immune-related adverse events (irAEs) developed during immunotherapy with anti-PD-1 agents, could be a predictive surrogate marker of clinical benefit in…”
Get full text

Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? by Lai, Eleonora, Astara, Giorgio, Ziranu, Pina, Pretta, Andrea, Migliari, Marco, Dubois, Marco, Donisi, Clelia, Mariani, Stefano, Liscia, Nicole, Impera, Valentino, Persano, Mara, Tolu, Simona, Balconi, Francesca, Pinna, Giovanna, Spanu, Dario, Pireddu, Annagrazia, Saba, Giorgio, Camera, Silvia, Musio, Francesca, Puzzoni, Marco, Pusceddu, Valeria, Madeddu, Clelia, Casadei Gardini, Andrea, Scartozzi, Mario

“…[Display omitted] •Advanced hepatocellular carcinoma remains a disease with poor prognosis.•Immunotherapy is an attractive strategy for advanced hepatocellular…”
Get full text

Molecular-Biology-Driven Treatment for Metastatic Colorectal Cancer by Lai, Eleonora, Liscia, Nicole, Donisi, Clelia, Mariani, Stefano, Tolu, Simona, Pretta, Andrea, Persano, Mara, Pinna, Giovanna, Balconi, Francesca, Pireddu, Annagrazia, Impera, Valentino, Dubois, Marco, Migliari, Marco, Spanu, Dario, Saba, Giorgio, Camera, Silvia, Musio, Francesca, Ziranu, Pina, Puzzoni, Marco, Demurtas, Laura, Pusceddu, Valeria, Dettori, Manuela, Massa, Elena, Atzori, Francesco, Dessì, Mariele, Astara, Giorgio, Madeddu, Clelia, Scartozzi, Mario

“…Metastatic CRC (mCRC) is a molecular heterogeneous disease. The aim of this review is to give an overview of molecular-driven treatment of mCRC patients. A…”
Get full text

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study by Cortellini, Alessio, Bersanelli, Melissa, Buti, Sebastiano, Gambale, Elisabetta, Atzori, Francesco, Zoratto, Federica, Parisi, Alessandro, Brocco, Davide, Pireddu, Annagrazia, Cannita, Katia, Iacono, Daniela, Migliorino, Maria R, Gamucci, Teresa, De Tursi, Michele, Sidoni, Tina, Tiseo, Marcello, Michiara, Maria, Papa, Anselmo, Angius, Gesuino, Tomao, Silverio, Fargnoli, Maria C, Natoli, Clara, Ficorella, Corrado

“…Tumors related to hereditary susceptibility seem to have an immunosensitive phenotype. We conducted a multicenter retrospective study, to investigate if family…”
Get full text

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the by Cortellini, Alessio, Bersanelli, Melissa, Buti, Sebastiano, Gambale, Elisabetta, Atzori, Francesco, Zoratto, Federica, Parisi, Alessandro, Brocco, Davide, Pireddu, Annagrazia, Cannita, Katia, Iacono, Daniela, Migliorino, Maria R, Gamucci, Teresa, De Tursi, Michele, Sidoni, Tina, Tiseo, Marcello, Michiara, Maria, Papa, Anselmo, Angius, Gesuino, Tomao, Silverio, Fargnoli, Maria C, Natoli, Clara, Ficorella, Corrado

“…Tumors related to hereditary susceptibility seem to have an immunosensitive phenotype. We conducted a multicenter retrospective study, to investigate if family…”
Get full text